Streptomyces tetracycline’s computational behavior against polyketide synthase of aflatoxigenic fungi


Original Article

Author Details : Medha Jyoti, Archana Kumari*, Maneesh Kumar, Ratnesh Kumar

Volume : 9, Issue : 2, Year : 2023

Article Page : 85-91

https://doi.org/10.18231/j.ijmmtd.2023.017



Suggest article by email

Get Permission

Abstract

Background: Streptomyces produces a variety of bioactive compounds that prevent fungal growth, including aflatoxins. Aflatoxigenic fungi (Aspergillus flavus and A. parasiticus) are being researched concerning Streptomyces spp. and can prevent the spread of aflatoxins-producing fungi. Aflatoxindegrading enzymes, which can convert poisonous aflatoxins into less dangerous compounds, are also produced by Streptomyces spp. The processes through which these microorganisms can be used to reduce
aflatoxins in food and agricultural systems are still the subject of active research.
Aim: To evaluate the novelty of tetracycline against the biosynthesis of aflatoxin in aflatoxigenic fungi via computational approach.
Materials and Methods: In this study, we performed molecular docking of polyketide synthase (Pks-A), an enzyme that initiates aflatoxin biosynthesis using tetracycline, using the online SeamDock server.
Result and Conclusion: Our results showed that tetracycline had a strong affinity for Pks-A in the binding pocket. The binding energy of tetracycline was -12.7 kcal/mol, indicating a strong binding affinity between the two molecules. Furthermore, the binding site was located in the active site, which is a conserved region in Pks-A and is essential for catalysing the formation of aflatoxin. The results of our docking study suggest that tetracycline may be an effective inhibitor of aflatoxin biosynthesis.


Keywords: Streptomyces, Polyketide synthase, Aflatoxigenic fungi, Tetracycline, Aflatoxin


How to cite : Jyoti M, Kumari A, Kumar M, Kumar R, Streptomyces tetracycline’s computational behavior against polyketide synthase of aflatoxigenic fungi. IP Int J Med Microbiol Trop Dis 2023;9(2):85-91


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 25-03-2023

Accepted : 18-04-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmmtd.2023.017


Article Metrics






Article Access statistics

Viewed: 633

PDF Downloaded: 124



Medical Abbreviation List